CERN Accelerating science

Published Articles
Title	Preclinical investigations and first-in-human application of $^{152}$Tb-PSMA-617 for PET/CT imaging of prostate cancer
Related title	Preclinical investigations and first-in-human application of $^{152}$Tb-PSMA-617 for PET/CT imaging of prostate cancer
Author(s)	Müller, Cristina (PSI, Villigen) ; Singh, Aviral (Unlisted, DE ; Unlisted, NL) ; Umbricht, Christoph A (PSI, Villigen) ; Kulkarni, Harshad R (Unlisted, DE) ; Johnston, Karl (CERN) ; Benešová, Martina (PSI, Villigen) ; Senftleben, Stefan (Unlisted, DE) ; Müller, Dirk (Unlisted, DE) ; Vermeulen, Christiaan (PSI, Villigen) ; Schibli, Roger (ETH, Zurich (main) ; PSI, Villigen) ; Köster, Ulli (Laue-Langevin Inst.) ; van der Meulen, Nicholas P (PSI, Villigen) ; Baum, Richard P (Unlisted, DE)
Publication	2019
Number of pages	10
In:	EJNMMI Res. 9 (2019) 68
DOI	10.1186/s13550-019-0538-1
Subject category	Other
Abstract	The results of this study demonstrate the successful preparation and preclinical testing of $^{152}$Tb-PSMA-617 and its first application in a patient with mCRPC. This work could pave the way towards clinical application of other Tb radionuclides in the near future, most importantly $^{161}$Tb, which has promising decay characteristics for an effective treatment of mCRPC patients.
Copyright/License	publication: © 2019-2025 The authors (License: CC-BY.4.0)

Corresponding record in: Inspire